By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IDBS said today it will be providing its Oncology Research Information System translational medicine platform for the Integrated Cancer Centre at King's Health Partners.

The deal, the UK data management and analytics solutions firm said, is the first step in a five-year relationship that may eventually include all disease areas including cancer disorders and cardiovascular diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.